On February 6–7, 2026, the 12th Europe Conference was held at Harvard Kennedy School. Under the theme “Crisis as Catalyst: Europe’s Opportunity in a Changing World Order,” the conference marked its 12th consecutive year and convened over 750 academics, students, policymakers, and emerging global leaders. Through 12 panels, flagship sessions, and fireside chats, discussions focused on the transatlantic relationship, innovation, and Europe’s evolving role in a multipolar world.

Tao Guoxin, Chief of Staff of MEBO Group, attended on behalf of Chairman Kevin Xu, former Chair of the APEC Host Committee. During the conference, he engaged with senior European leaders and policy figures to exchange views on regional cooperation, green innovation, and investment development.

MEBO’s participation underscores its commitment to strengthening international collaboration and advancing strategic engagement with Europe.

About MEBO

Founded in 1987 by Professor Rongxiang Xu, a distinguished Chinese life scientist, MEBO Group is a multinational headquartered in both China and the USA. It integrates research, development, and sales across the pharmaceuticals, medical devices, health foods, and cosmetics sectors.

At its core, MEBO focuses on regenerative life sciences, innovating with over 100 patents and more than ten joint research bases to enhance and enable the body's own regenerative abilities.

As a leader in regenerative life science, MEBO's extensive research facilities and products impact over 100 countries globally, pioneering new frontiers in the regenerative life world.